Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.
2.

Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.

Grossberg GT, Edwards KR, Zhao Q.

J Clin Pharmacol. 2006 Jul;46(7 Suppl 1):17S-26S. Review.

PMID:
16809811
3.

Enantiomeric resolution of galanthamine and related drugs used in anti-Alzheimer therapy by means of capillary zone electrophoresis employing derivatized cyclodextrin selectors.

Rizzi A, Schuh R, Brückner A, Cvitkovich B, Kremser L, Jordis U, Fröhlich J, Küenburg B, Czollner L.

J Chromatogr B Biomed Sci Appl. 1999 Jul 9;730(2):167-75.

PMID:
10448951
4.

[Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].

Schwalbe O, Wunderlich S, Kloft C.

Med Monatsschr Pharm. 2006 Jun;29(6):222-4. German.

PMID:
16792199
5.

[Medical treatment of Alzheimer's disease].

Johannsen P.

Ugeskr Laeger. 2006 Oct 2;168(40):3424-9. Review. Danish.

PMID:
17032609
6.

[Galanthamine versus donepezil in the treatment of Alzheimer's disease].

López-Pousa S, Garre-Olmo J, Vilalta-Franch J.

Rev Neurol. 2007 Jun 1-15;44(11):677-84. Review. Spanish.

7.
9.
10.

Review of the acetylcholinesterase inhibitor galanthamine.

Sramek JJ, Frackiewicz EJ, Cutler NR.

Expert Opin Investig Drugs. 2000 Oct;9(10):2393-402. Review.

PMID:
11060814
11.

Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine.

Capellà D, Vidal X.

Age Ageing. 2007 Mar;36(2):234; author reply 235. Epub 2007 Jan 25. No abstract available.

PMID:
17255086
12.

Evaluation of four Narcissus cultivars as potential sources for galanthamine production.

Moraes-Cerdeira RM, Burandt CL Jr, Bastos JK, Nanayakkara D, Mikell J, Thurn J, McChesney JD.

Planta Med. 1997 Oct;63(5):472-4.

PMID:
9342954
13.

An update on the pharmacology of galantamine.

Villarroya M, García AG, Marco-Contelles J, López MG.

Expert Opin Investig Drugs. 2007 Dec;16(12):1987-98. Review.

PMID:
18042006
14.

Galantamine improves gait performance in patients with Alzheimer's disease.

Assal F, Allali G, Kressig RW, Herrmann FR, Beauchet O.

J Am Geriatr Soc. 2008 May;56(5):946-7. doi: 10.1111/j.1532-5415.2008.01657.x. No abstract available.

PMID:
18454755
15.

Galanthamine.

Fulton B, Benfield P.

Drugs Aging. 1996 Jul;9(1):60-5; discussion 66-7. Review.

PMID:
8818586
16.

[Pharmacotherapy for Alzheimer's disease].

Verhey FR.

Tijdschr Psychiatr. 2006;48(1):17-26. Review. Dutch.

17.

A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.

Chu LW, Yik PY, Mok W, Chung CP.

Int J Clin Pract. 2007 Mar;61(3):403-10.

PMID:
17313606
18.

Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.

Martinez A, Castro A.

Expert Opin Investig Drugs. 2006 Jan;15(1):1-12. Review.

PMID:
16370929
20.

Treatment for Alzheimer's disease.

Wilcock GK.

Int J Geriatr Psychiatry. 2000 Jun;15(6):562-5. No abstract available.

PMID:
10861924

Supplemental Content

Support Center